INDEPENDENT NEWS

AIA introduces bold changes to NZ health insurance market

Published: Thu 1 Oct 2015 12:06 PM
Media release: Embargoed until 5.00pm, Wednesday 30 September
AIA introduces bold changes to NZ health insurance market
30 September, 2015 – AIA today signalled its growth intentions with enhancements to its personal product range, and launching with a new health product that lifts medical cover to $500,000, with a discount regime to make their insurance products more affordable for customers.
The new Real Health product introduces new $500,000 limits on surgical and non-surgical treatments, including new generation, non-Pharmac treatments for cancer, such as the innovative immunotherapy treatments, that are otherwise unaffordable for the average New Zealander.
Chief executive Natalie Cameron says: “Our new Real Health policy directly addresses the affordability issues for these new treatments, but we’re also moving to address the general affordability of insurance cover for the average New Zealander by introducing a generous discount regime on premiums.”
AIA customers who purchase the Real Life policy together with other insurance policies receive an escalating discount per extra policy.
“The more policies that are bundled up, the greater the discount that is available,” Cameron says.
The two initiatives, taken together, will increase the number of New Zealanders gaining access to the latest life-saving drugs and treatments, she added.
“These new drugs and treatments are coming to market quickly and although there is uncertainty around when and how much they will cost, we can be sure that costs will continue to rise,” comments Cameron. “The insurance industry is about effectively managing risk and we are introducing this new product now in the expectation that New Zealanders will need that level of support in the near future.”
As the second largest life insurer in the world, AIA is serious about investing in the New Zealand insurance industry, Cameron says. “The AIA group has a market capitalisation of $116.34b, and that gives us the economies of scale to provide New Zealand families with an affordable choice,” Cameron adds.
“We aim to be a serious industry player offering innovative products, with real benefits, that are more relevant to people’s lives than our competitors’ offering.”
ENDS

Next in Business, Science, and Tech

General Practices Begin Issuing Clause 14 Notices In Relation To The NZNO Primary Practice Pay Equity Claim
By: Genpro
Global Screen Industry Unites For Streaming Platform Regulation And Intellectual Property Protections
By: SPADA
View as: DESKTOP | MOBILE © Scoop Media